Search Medical Condition
Please enter condition
Please choose location from dropdown

Atrial Fibrillation Clinical Trials

A listing of Atrial Fibrillation medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (601) clinical trials

To evaluate the use of a resynchronization defibrillator (or CRT-D) versus a CRT-D and ablation to treat permanent AF.

Phase N/A

The purpose of this study is to compare the safety and efficacy of the convergent procedure as compared to an endocardial (inside the heart) catheter ablation procedure for the treatment of persistent atrial fibrillation. Participant will receive either the convergent procedure or the endocardial catheter ablation procedure. The convergent procedure ...

Phase N/A

The purpose of this study is to provide information about the safety and long-term effectiveness of the QDOT MICRO™ Catheter for the treatment of subjects with Paroxysmal Atrial Fibrillation (PAF) who have failed at least one antiarrhythmic drug (medication to treat symptoms of PAF). The QDOT MICRO™ Catheter is an ...

Phase N/A

Prospective, non-randomized, post market clinical evaluation of the VISITAG SURPOINT™ Module with External Processing Unit (EPU) when used with STSF catheter and ST catheter compared to an historical control performance goal. A maximum of 330 subjects will be enrolled across up to 45 sites. Two hundred eighty (280) enrolled subjects ...

Phase N/A

The primary objective is to understand the role of ATP in primary prevention patients indicated for ICD therapy. The incidence of all-cause shocks in subjects programmed with shocks only will be compared with subjects programmed to standard therapy (ATP and shock) to assess equivalency. Multivariate analyses will also be performed to ...

Phase N/A

The purpose of this research study is to collect information on the safety of the TactiCath SE ablation catheter when it is used to treat atrial fibrillation in people like you. This study will collect information about the success of the procedure and report on the number and type of ...

Phase N/A

The primary objective is to show the benefit of SmartDelay™ in patients with a prolonged RV-LV interval.

Phase N/A

To determine if the use of apixaban in patients with SCAF will reduce the incidence of stroke and systemic embolism compared to aspirin.

Phase N/A

This study is a prospective, randomized, multi-center, global investigation to determine the safety and effectiveness of the WATCHMAN Device for subjects with non-valvular atrial fibrillation who are deemed not suitable for anticoagulation therapy to reduce the risk of stroke.

Phase N/A

Atrial fibrillation affects approximately 2 million Americans according to the American Heart Association. This patient population comprises a substantial portion of patients seen at Baptist Health Lexington. Means of treatment includes pharmacological therapy for controlling both the rate and rhythm. In many cases, also anticoagulants are also necessary to prevent ...

Phase N/A